Related Experiment Video
Updated: Jun 8, 2025
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
42
Cannabis Vaping Among US Adults With Disabilities: Findings From the 2022 Behavioral Risk Factor Surveillance System
Erinoso Olufemi1, Osibogun Olatokunbo2, Li Wei3
1Department of Health Behavior, Policy, and Administration Sciences, School of Public Health, University of Nevada, Reno, Reno, NV, USA.
Public Health Reports (Washington, D.C. : 1974)
|November 8, 2024
Summary
Cannabis vaping is more common in adults with disabilities, especially those with cognitive disabilities. Nicotine vaping and past smoking increase cannabis vaping risk, highlighting the need for interventions against polysubstance use.
Area of Science:
- Public Health
- Epidemiology
- Substance Use Research
Background:
- Previous studies indicate higher cannabis use among individuals with disabilities.
- Limited research exists on specific use patterns, such as cannabis vaping, within this population.
Purpose of the Study:
- To investigate the prevalence and correlates of cannabis vaping among adults with disabilities.
- To examine the association between cannabis vaping and the frequency of overall cannabis use.
Main Methods:
- Utilized 2022 Behavioral Risk Factor Surveillance System data for US adults.
- Employed weighted multivariable logistic and modified Poisson regression models to analyze associations.
Main Results:
- Cannabis vaping prevalence was higher in adults with any disability (4.6%) compared to those without (2.8%), with cognitive disabilities showing the highest rate (8.2%).
- Nicotine vaping, former cigarette smoking, and younger age (18-24 years) were significantly associated with increased odds of cannabis vaping in adults with disabilities.
- Disability status moderated the link between cigarette smoking and cannabis vaping. Adults with disabilities who vaped cannabis reported more frequent cannabis use days.
Conclusions:
- Nicotine vaping is linked to cannabis vaping among adults with disabilities.
- Findings underscore the necessity for interventions targeting polysubstance use (nicotine and cannabis) in this demographic.
Related Concept Videos
01:29Stimulants
159
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
159
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:30Specialized Care Centers and Settings-II
716
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
716
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K